Xuben Yu
Impact in
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
- Treatment of Major Depression
Papers in
- Pharmacology 17
- Antibiotics Pharmacokinetics and Efficacy 16
- Treatment of Major Depression 1
-
- Tryptophan and brain disorders 3
- Co-authors
- Ying Dai (12 shared papers)Ziye Zhou (12 shared papers)Guanyang Lin (13 shared papers)Chunhong Zhang (10 shared papers)Abhimanyu Thakur (1 shared paper)Haina Zhang (6 shared papers)Jingye Pan (5 shared papers)Lu Han (3 shared papers)
- Journals
- Frontiers in Pharmacology (5 papers)Psychopharmacology (3 papers)British Journal of Clinical Pharmacology (3 papers)The International Journal of Neuropsychopharmacology (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)
- Partner nations
- ChinaSouth KoreaUnited States
In The Last Decade
Xuben Yu
35 papers receiving 574 citations
Peers
Comparison fields: 5 of 55
- Biological Psychiatry 15
- Pharmacology 180
- Molecular Medicine 31
- Toxicology 9
- Developmental Neuroscience 6
Countries citing papers authored by Xuben Yu
This map shows the geographic impact of Xuben Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuben Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuben Yu more than expected).
Fields of papers citing papers by Xuben Yu
This network shows the impact of papers produced by Xuben Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuben Yu. The network helps show where Xuben Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xuben Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 96 | |
| 2 | 2018 | 51 | |
| 3 | 2020 | 50 | |
| 4 | 2022 | 44 | |
| 5 | 2021 | 31 | |
| 6 | 2015 | 30 | |
| 7 | 2022 | 30 | |
| 8 | 2020 | 29 | |
| 9 | 2015 | 23 | |
| 10 | 2021 | 22 | |
| 11 | 2019 | 21 | |
| 12 | 2019 | 17 | |
| 13 | 2022 | 17 | |
| 14 | 2022 | 17 | |
| 15 | 2021 | 12 | |
| 16 | 2022 | 12 | |
| 17 | 2022 | 11 | |
| 18 | 2019 | 10 | |
| 19 | 2021 | 10 | |
| 20 | 2023 | 7 |
About Xuben Yu
Xuben Yu is a scholar working on Pharmacology, Biological Psychiatry, Analytical Chemistry, Developmental Neuroscience and Geriatrics and Gerontology, having authored 39 papers that have together received 580 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (16 papers), Tryptophan and brain disorders (3 papers), Analytical Methods in Pharmaceuticals (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (1 paper), Nanoparticle-Based Drug Delivery (1 paper), Sirtuins and Resveratrol in Medicine (1 paper), Neurogenesis and neuroplasticity mechanisms (1 paper) and Treatment of Major Depression (1 paper). The work is most often cited by research in Biological Psychiatry (15 citations), Pharmacology (180 citations), Molecular Medicine (31 citations), Toxicology (9 citations) and Developmental Neuroscience (6 citations). Xuben Yu has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Ying Dai, Ziye Zhou, Guanyang Lin, Chunhong Zhang, Abhimanyu Thakur, Haina Zhang, Jingye Pan, Lu Han, Hongbin Sun and Lu Han. Their work appears in journals such as Frontiers in Pharmacology, Psychopharmacology, British Journal of Clinical Pharmacology, The International Journal of Neuropsychopharmacology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.